Dr Wong did his undergraduate training at University of Cambridge and St Bartholomew’s and the Royal London School of Medicine and Dentistry, UK, from 1994 to 1999. He was awarded Distinction in Medicine and received several undergraduate prizes. He was also awarded First Class Honours and Distinction award for Bachelor of Science degree in Neuroscience at University College London in 1997. Post-graduation, he obtained his MRCP (UK) in 2003 and was conferred the Doctor of Medicine (M.D.) degree by University of Cambridge in 2013.
He started training in the field of Cardiology at the Wessex Deanery (UK) in 2003. He undertook sub-specialty training in Cardiac Electrophysiology and Cardiac Rhythm Management in 2007. From 2008 to 2010, he was appointed the Research Fellow for Electrophysiology at the John Radcliffe Hospital, Oxford, UK. His research work on atrial fibrillation ablation was submitted as a thesis for his Doctorate degree to University of Cambridge. He underwent further training as the Senior Electrophysiology Fellow at Oxford before obtaining his Certificate of Completion of Training (CCT) in Cardiology and General (Internal) Medicine in 2011. He was then appointed as Locum Consultant at John Radcliffe Hospital, Oxford University Hospitals NHS Trust, in 2012.
Dr Wong returned to Singapore in 2014 as Consultant Cardiologist at Changi General Hospital and visiting Consultant to National Heart Centre Singapore. He was instrumental in helping to develop the Electrophysiology service at Changi General Hospital. He helped set up specialised clinics such as the Inherited Cardiac Conditions clinic and the Atrial Fibrillation clinic. He is experienced in treating patients with cardiac arrhythmia. He is competent in performing device implantations (pacemaker, defibrillator) and complex ablations for arrhythmia. He continues to offer proctorship services to countries such as Malaysia, India and Vietnam.
Dr. Tan attended the University College Dublin in Ireland and was conferred with MB BCh BAO medical degree by the National University of Ireland in the year 2004. He subsequently completed his residency in Internal Medicine and obtained his post graduate MRCP (UK) London in 2009.
He then underwent further specialization in Cardiology with the Advanced Specialist Training Program and was accredited by the Specialist Registry of Singapore as a Cardiologist in the year 2013. Following that he accepted the position of Associate Consultant Cardiologist in Changi General Hospital and was subsequently promoted to a Consultant in 2015.
Dr. Tan started to practice as an Interventional Cardiologist since 2013 focusing on managing patient with occluded coronary arteries in both emergency as well as elective settings. He treated patients who presented with major heart attack needing immediate ballooning and stenting of the blocked arteries of the heart. He also received further training as an Interventional Cardiologist from University of Ottawa Heart Institute, Canada in 2015 and 2016 managing patients with more complex coronary artery diseases and chronic total occlusions. During his Fellowship in Canada, he was a member of the Heart Team in Transcatheter Aortic Valve Replacement dealing with patients with severe Aortic Stenosis not suitable for surgical valve replacement.
Dr. Tan was the Coronary Care Unit Director in Changi General Hospital and played a major role in educating junior doctors in Cardiology on managing critically ill patients in the Coronary care Unit. His previous educational profile would also include Senior Clinical Lecturer with the Yong Loo Lin School of Medicine, National University Hospital Singapore.
Dr. Tan is also currently a member of the Fellow of Academy of Medicine Singapore in the Cardiology Chapter.
Dr Woo Jia Wei is an Internist and Cardiologist with Sunrise General Medical and Heart Services. He is also a Visiting Consultant Cardiologist to National University Heart Centre Singapore.
His special interests lie in advanced multimodality cardiac imaging for accurate and in depth cardiac diagnoses using state of the art technology. He is also experienced in using advanced 3D cardiac imaging techniques using CT, MRI and echocardiography to guide and plan various heart procedures and surgeries to facilitate smooth operation. He also has an interest in preventive and community cardiology to act on and prevent heart attacks and other cardiovascular events at the earliest stages.
He was formally trained in Cardiovascular MRI at the German Heart Centre in Berlin, a leading international cardiovascular centre. He was trained in using cardiac MRI to diagnose and manage coronary artery disease as well as various cardiomyopathies. He also had exposure to patients with complex congenital heart diseases.
He also received formal training in cardiac CT with world renowned John Hopkins Hospital in America as well as with Harefield Hospital in the United Kingdom. He subsequently received a Diplomate in Cardiac CT from the Certification Board of Cardiovascular Computed Tomography of America.
He trained in adult echocardiography with trans-esophageal echocardiography and transthoracic echocardiography at the National University Heart Centre. He subsequently received a Diplomate in adult echocardiography from the American Society of Echocardiography. He also has experience in interventional echocardiography and use of 3D and 4D imaging techniques to guide minimally invasive cardiac procedures.
He had also presented in several International Cardiology and Medical Conferences as guest speaker and published in several International Peer-reviewed journals. He was also appointed to be a reviewer in several international journals.
Dr John Chia graduated with double distinctions in Medicine and Surgery from the National University of Singapore in 1999 and obtained his Membership of the Royal College of Physicians in Edinburgh in 2002. Very early on in his career, he was actively engaged with the then nascent field of immunotherapy for solid cancers, and heavily involved with the leadership or development of 7 immunotherapy clinical trials in Singapore. Following his Oncology Boards, he undertook his post graduate fellowship with Professor Malcom Brenner between 2008 and 2009 – in the field of Immunotherapy for Solid Tumours – namely in the development of dendritic cancer vaccines, adoptive T cell therapy, and immune biomarker monitoring for cancers. In 2011 and 2012, he completed a second fellowship with Professor Stan Kaye at The Royal Marsden Hospital London for the Advanced Management of Gynaecological cancers.
Dr Chia is extremely active in clinical trial research and has developed numerous research protocols and trials for ovarian, cervical, colorectal, nasopharyngeal, and breast cancer in Singapore. He has published widely in leading international journals and holds numerous local and international research grants exceeding 10 million dollars – for clinical research exploring immune check-point inhibitors, cancer vaccines, T cell therapy, chemoprevention with Aspirin, and small molecule inhibitors for cancer. In 2010, he was awarded “Best Poster” for a tumor-specific cancer vaccine trial at the European Society of Medical Oncology, Milan (amongst several thousand submissions), and more recently “Best Poster” at ESMO Asia in 2017, for his clinical trial in aggressive ovarian cancer.
Dr Toh is a medical oncologist who sub-specializes in thoracic oncology including lung cancers and thymic cancers, genitourinary oncology including prostate, kidney, bladder and testicular cancers, as well as head and neck cancers.
He graduated from National University of Singapore with the Gibb’s gold medal in 1995, followed by MRCP (UK) in 2000 and specialist accreditation in Medical Oncology in 2004. He spent time at Burnham Institute in La Jolla and Roger Moores Cancer Centre in San Diego under the Health Manpower Development Programme award. He was working at the National Cancer Centre Singapore for majority of his career, with a 3 year-stint intercalated at Raffles Cancer Centre where he was director of clinical research, before joining Curie Oncology.
Throughout the years, he was involved in clinical work, clinical trials and teaching. Among his many achievements, he was one of the first who published on the clinical characteristics of lung cancer among the never-smokers. That was at the time when the molecular characteristic of this group of patients was not known yet. It was later discovered that lung cancer in never-smokers formed a big group in our Asian population. He was the lead of the Lung Cancer Consortium project at National Cancer Centre to coordinate lung cancer research in Singapore, which paved the way for many publications and discoveries. He was also part of the team of the Large Collaborative Grant on ‘Next-Generation Clinical Trials and Integrative Research for Fighting Lung Cancer’ awarded by National Medical Research Council. During the early years, he was one of few oncologists in Singapore to administer high dose interleukin-2 as a form of immunotherapy treatment for kidney cancer and melanoma. Immunotherapy then transitioned to checkpoint inhibitors over the years and became a cornerstone in the treatment of many cancers now. He has led and was a co-investigator in many clinical trials. He was also a member in the workgroup for the Singapore Cancer Network (SCAN) guidelines for lung cancer, kidney cancer, prostate cancer and bladder cancer. In the area of teaching, he was assistant professor at the Yong Loo Lin School of Medicine, NUS and Duke-NUS medical school.
Dr Kiley Loh is a medical oncologist specializing in breast cancers and cancer supportive and survivorship care, leading Curie Oncology’s services in Malaysia at the Penang Adventist Hospital.
Dr Loh graduated from the University of Melbourne in 2005, before undergoing medical oncology training with the Victorian Medical Oncology Training Program at several Melbourne-based hospitals, including the Peter MacCallum Cancer Centre. He joined National Cancer Centre Singapore (NCCS) in 2014 after the completion of his training and went on to subspecialize in the field of breast cancers.
At NCCS, Dr Loh led the center’s cancer supportive and survivorship care initiatives and research to better support cancer patients through their treatment journey as well as into their long-term survivorship. His work and collaborations have resulted in the development of the ACCESS program at NCCS which proactively detects and addresses physical and psychosocial problems amongst cancer patients. Dr Loh has also led clinical trials to investigate novel approaches to reduce, prevent and better manage cancer treatment-related side effects.
Beyond his work in breast cancers and cancer supportive and survivorship care, Dr Loh is also passionate in the field of cancer education leading to various education leadership roles at NCCS. He was the Director of Cancer Education and Information Services as well as the Deputy Director of Undergraduate Education with the Division of Cancer Education.
Dr Ooi Wei Seong is a medical oncologist who graduated from Trinity College Dublin with honours distinction in 1999. He started his oncology training at St Vincent’s University Hospital in Dublin and then spent three years at Sunnybrook Odette Cancer Centre in Toronto, Canada as a clinical fellow in oncology. He then returned to Singapore and obtained his specialist accreditation in medical oncology.
Dr Ooi Wei Seong has keen interest and expertise in lung, breast, and colon cancers, and is frequently updated on the latest treatments for cancer at renowned medical oncology conferences in the USA, Europe, and Asia at least 4 times a year. In addition to the management of all solid tumour types, he also has special interest in bone health and mechanisms of bone metastases in cancer patients. Dr Ooi was a recipient of the Singapore Health Quality Service Award in 2011 for his exemplary service to patients.
Dr Ooi Wei Seong is actively involved with multiple investigator-initiated and pharmaceutical-led clinical trials. He has also contributed to publications in peer-reviewed journals. His research has been presented at various international oncology meetings. Dr Ooi has given talks to overseas oncologists and general practitioners on managements of cancers in the region. He has also spoken at local GP symposiums and conducted Cancerwise workshops, public forums aimed at providing comprehensive information on specific cancers. He was a Clinical Tutor at Yong Loo Lin School of Medicine at the National University of Singapore in addition to providing teachings to junior doctors, nurses, Duke-NUS students, and elective fellows.
Dr. Agasthian graduated from National Unversity of Singapore with an MBBS and was admitted as Fellow to the Royal College of Surgeons (Edinburgh and Glasgow) in 1989 and 1990 respectively. He further advanced his skills in cardiothoracic surgery in MAYO Clinic, Rochester, Minnesota, USA from 1994 to 1995 and at the Cleveland Clinic, Cleveland, Ohio, USA from 1995 to 1996.
Dr. Agasthian has been extensively consulted and sits on the panel of many illustrious international advisory boards and committees including national committees for respiratory disease and cardiothoracic surgery as well as programmes for heart and lung transplants. Over and above the routine surgical procedures, Dr. Agasthian has a subspecialty and research interest in:
- Esophaegeal Dieases
- Lung Diseases
- Lung Volume Reduction Surgery
- Lung Transplantation
- Airway Reconstruction
- Thoracoscopy / Minimally Invasive Surgery / VIDSO Assisted Thoracoscopic Surgery / VATS
- Paediatric Thoracic Surgery
He has made numerous presentations in his area of expertise and has published in international journals including Asian Annals of Cardiovascular and Thoracic Surgery.
Dr Loh Yee Jim was formerly the Head of Cardiothoracic Surgery at KK Women’s and Children’s Hospital (KKH) in Singapore. Besides being experienced in the delicate nature of paediatric heart surgery, Dr Loh is also actively involved in adult cardiac surgical work, including coronary artery bypass grafting (CABG) and valvular repair/replacements. He started the use of minimally invasive cardiac surgery with video-assisted thoracoscopic (VATS) / totally endoscopic closure of atrial septal defects. He has also performed the largest series of aortic valve sparing root replacement procedures in Singapore, benefitting patients with aortic root aneurysms.
He has been active in advancing the Cardiothoracic profession in Singapore over the years and he was an Adjunct Assistant Professor at the Duke-NUS Graduate Medical School, and a Clinical instructor at the Yong Loo Lin School of Medicine between 2013 to 2018. He was appointed by the Ministry of Health (MOH) to be part of the Residency Advisory Committee (RAC). He was also one of the principal members of the physician faculty of the Cardiothoracic Residency training program in Singapore.
He has held appointments as the Programme and Medical Director at the National Cardiovascular Homograft Bank, as well as the Surgical Director of the KKH ECMO program, and as the co-director of the National Paediatric Heart Transplant and Ventricular Assist Device program.
Dr Loh was a fellow at the Harvard Medical School in Boston where he did a fellowship in Paediatric Cardiac Surgery. He worked with Dr Pedro del Nido, and was appointed to the position of Chief Resident during his fellowship. He is also a fellow of the Royal College of Surgeons (Edinburgh). He is an alumnus of the National University of Singapore, where he received his MBBS in 2000.
He has published numerous research articles to date, and maintains an active interest in ongoing advances in medical technology.